As the Johnson & Johnson Family of Companies continues to grow and we look toward opportunities and challenges of the future, it is important for us to regularly assess our organizations to ensure that they remain focused strategically, resourced properly and structured appropriately.
Today I am announcing organizational realignments within our leadership team that are being taken to ensure that we continue to be well positioned for sustainable growth into the future. Our organizational changes are an appropriate step in furthering our long-term succession plans within Johnson & Johnson, assuring talented, experienced leaders at all levels of the organization. The changes remain consistent with our philosophy of decentralization and are designed to improve Johnson & Johnson's capacity to grow and to provide a platform for effective and efficient operations.
Our Company
Today's Organizational Announcements
Today's Top Reads
Close
-
Did you like reading this story? Click the heart to show your love.
38 -
Did you like reading this story? Click the heart to show your love.
57 -
Did you like reading this story? Click the heart to show your love.
32
Earlier today, we issued a press release announcing that Alex Gorsky, currently Worldwide Chairman, Medical Devices & Diagnostics and Sheri McCoy, currently Worldwide Chairman, Pharmaceuticals, have been appointed Vice Chairmen of the Executive Committee and join William C. Weldon, Chairman of the Board and Chief Executive Officer, in an expanded Office of the Chairman. Both appointments are effective January 3, 2011. In the communication distributed globally to all Johnson & Johnson employees, Bill summed up these organizational changes in the following way: